Business
Resolutions from Zealand Pharma's Annual General Meeting 2026
Company announcement – No. 5 / 2026 Resolutions from Zealand Pharma's Annual General Meeting 2026 Copenhagen, Denmark, March 26, 2026 - Zealand Pharma A/S ("Zealand Pharma" or the “Company”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today held its Annual General Meeting of 2026 as a partly electronic and partly physical general meeting (hybrid meeting). At the Annual General Meeting, all proposals presented to the Annual General Meeti
About this update from Zealand Pharma A/s
[{"type":"image","alt":"Zealand Pharma","displaySize":"","headline":null,"caption":"Zealand Pharma","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":121,"url":"https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/hruCjDK29WWlg5.YGk148A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE2OQ--/https://media.zenfs.com/en/globenewswire.com/2567d307984f8639b4a7711f51c64eff","width":300,"height":121}},"lazy":false},{"type":"text","content":"Company announcement – No. 5 / 2026","length":35,"tagName":"p"},{"type":"text","content":"Resolutions from Zealand Pharma's Annual General Meeting 2026","length":65,"tagName":"p"},{"type":"text","content":"Copenhagen, Denmark, March 26, 2026 - Zealand Pharma A/S ("Zealand Pharma" or the “Company”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today held its Annual General Meeting of 2026 as a partly electronic and partly physical general meeting (hybrid meeting).","length":329,"tagName":"p"},{"type":"text","content":"At the Annual General Meeting, all proposals presented to the Annual General Meeting were approved, save for the non-binding advisory vote on the remuneration report under item 7 on the agenda.","length":193,"tagName":"p"},{"type":"text","content":"Resolutions considered at the Annual General Meeting:","length":53,"tagName":"p"},{"type":"text","content":"Annual ReportThe Annual General Meeting acknowledged the management's report on Zealand Pharma's activities in the past financial year and Zealand Pharma's audited Annual Report for 2025 was approved.","length":213,"tagName":"p"},{"type":"text","content":"The Annual General Meeting also approved that the financial result for 2025, which was a net profit after tax of TDKK 6,455,008, was carried forward to the next financial year.","length":176,"tagName":"p"},{"type":"text","content":"Board elections, composition and committeesThe following existing shareholder-elected board members were re-elected to the Board of Directors as recommended by Zealand Pharma's Nomination Committee:","length":203,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Martin Nicklasson","length":17,"tagName":"p"}]},{"val":[{"type":"text","content":"Kirsten Aarup Drejer","length":20,...